Back
Monopar Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Buy
75
MNPR
Monopar Therapeutics
Last Price:
25.37
Seasonality Move:
35.55%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.27 | Buy |
| 20-day SMA: | 21.39 | Buy |
| 50-day SMA: | 15.61 | Buy |
| 200-day SMA: | 6.55 | Buy |
| 8-day EMA: | 23.46 | Buy |
| 20-day EMA: | 21.41 | Buy |
| 50-day EMA: | 16.75 | Buy |
| 200-day EMA: | 8.67 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.38 | Buy |
| Relative Strength Index (14 RSI): | 67.67 | Buy |
| Chaikin Money Flow: | 30154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.15 - 23.13) | Buy |
| Bollinger Bands (100): | (1.48 - 17.5) | Buy |
Monopar Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 25.38 while MNPR 8-day simple moving average is 23.27, which is a Buy signal.
- The stock price of MNPR is 25.38 while Monopar Therapeutics 20-day SMA is 21.39, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 15.61 while MNPR share price is 25.38, making it a Buy technically.
- MNPR stock price is 25.38 and Monopar Therapeutics 200-day simple moving average is 6.55, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $25.38. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
133.95M
Price in USD:
25.38
Share Volume:
47.31K
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.40
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 25.38 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 25.38 while MNPR 8-day exponential moving average is 23.46, which is a Buy signal.
- The stock price of MNPR is 25.38 while Monopar Therapeutics 20-day EMA is 21.41, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 16.75 while MNPR share price is 25.38, making it a Buy technically.
- MNPR stock price is 25.38 and Monopar Therapeutics 200-day simple moving average is 8.67, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is 2.38, suggesting Monopar Therapeutics is a Buy
- Monopar Therapeutics Relative Strength Index (RSI) is 67.67, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (18.15 - 23.13), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (1.48 - 17.5), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.